65 related articles for article (PubMed ID: 16541325)
1. The Effects of Nurse-Led Supportive Care Program on Quality of Life in Women with Breast Cancer Receiving Adjuvant Chemotherapy: A Randomized Controlled Pilot Study.
Yazicioglu Kucuk B; Zorba Bahceli P
Semin Oncol Nurs; 2024 Apr; 40(2):151609. PubMed ID: 38433074
[TBL] [Abstract][Full Text] [Related]
2. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
Moore HC; Unger JM; Phillips KA; Boyle F; Hitre E; Porter D; Francis PA; Goldstein LJ; Gomez HL; Vallejos CS; Partridge AH; Dakhil SR; Garcia AA; Gralow J; Lombard JM; Forbes JF; Martino S; Barlow WE; Fabian CJ; Minasian L; Meyskens FL; Gelber RD; Hortobagyi GN; Albain KS;
N Engl J Med; 2015 Mar; 372(10):923-32. PubMed ID: 25738668
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant ovarian suppression in premenopausal breast cancer.
Francis PA; Regan MM; Fleming GF; Láng I; Ciruelos E; Bellet M; Bonnefoi HR; Climent MA; Da Prada GA; Burstein HJ; Martino S; Davidson NE; Geyer CE; Walley BA; Coleman R; Kerbrat P; Buchholz S; Ingle JN; Winer EP; Rabaglio-Poretti M; Maibach R; Ruepp B; Giobbie-Hurder A; Price KN; Colleoni M; Viale G; Coates AS; Goldhirsch A; Gelber RD; ;
N Engl J Med; 2015 Jan; 372(5):436-46. PubMed ID: 25495490
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.
Regan MM; Pagani O; Fleming GF; Walley BA; Price KN; Rabaglio M; Maibach R; Ruepp B; Coates AS; Goldhirsch A; Colleoni M; Gelber RD; Francis PA; ;
Breast; 2013 Dec; 22(6):1094-100. PubMed ID: 24095609
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Munster PN; Moore AP; Ismail-Khan R; Cox CE; Lacevic M; Gross-King M; Xu P; Carter WB; Minton SE
J Clin Oncol; 2012 Feb; 30(5):533-8. PubMed ID: 22231041
[TBL] [Abstract][Full Text] [Related]
6. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for premenopausal patients with early breast cancer.
Kurebayashi J
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):51-4. PubMed ID: 18197006
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
9. A graphical LASSO analysis of global quality of life, sub scales of the EORTC QLQ-C30 instrument and depression in early breast cancer.
Poikonen-Saksela P; Kolokotroni E; Vehmanen L; Mattson J; Stamatakos G; Huovinen R; Kellokumpu-Lehtinen PL; Blomqvist C; Saarto T
Sci Rep; 2022 Feb; 12(1):2112. PubMed ID: 35136160
[TBL] [Abstract][Full Text] [Related]
10. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
[TBL] [Abstract][Full Text] [Related]
11. Using a retrospective pretest instead of a conventional pretest is replacing biases: a qualitative study of cognitive processes underlying responses to thentest items.
Taminiau-Bloem EF; Schwartz CE; van Zuuren FJ; Koeneman MA; Visser MR; Tishelman C; Koning CC; Sprangers MA
Qual Life Res; 2016 Jun; 25(6):1327-37. PubMed ID: 26573019
[TBL] [Abstract][Full Text] [Related]
12. Are there efficacious treatments for treating the fatigue-sleep disturbance-depression symptom cluster in breast cancer patients? A Rapid Evidence Assessment of the Literature (REAL(©)).
Jain S; Boyd C; Fiorentino L; Khorsan R; Crawford C
Breast Cancer (Dove Med Press); 2015; 7():267-91. PubMed ID: 26379445
[TBL] [Abstract][Full Text] [Related]
13. The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach.
Post WJ; Buijs C; Stolk RP; de Vries EG; le Cessie S
Qual Life Res; 2010 Feb; 19(1):137-48. PubMed ID: 20041307
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.
Montazeri A
J Exp Clin Cancer Res; 2008 Aug; 27(1):32. PubMed ID: 18759983
[TBL] [Abstract][Full Text] [Related]
15. The role of ovarian ablation in the adjuvant therapy of breast cancer.
Tan SH; Wolff AC
Curr Oncol Rep; 2008 Jan; 10(1):27-37. PubMed ID: 18366958
[TBL] [Abstract][Full Text] [Related]
16. Current controversies in the management of early breast cancer.
Estévez LG; Martín M; Alba E; Colomer R; Lobo F; Lluch A; Adrover E; Albanell J; Barnadas A; García-Mata J; Llombart A; Muñoz M; Rodríguez C; Sánchez-Rovira P; Seguí MA; Tusquets I
Clin Transl Oncol; 2007 Jun; 9(6):375-84. PubMed ID: 17594952
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
